Healiva’s Wound Care & Skin Diseases proprietary Platform Technology includes an end-to-end approach with enzyme technology and cell therapies for wound care and skin diseases. The platform can diversify into vitiligo management, skin regeneration or sports injury applications.

Products, services, technology

Epidex® is an autologous cell graft promoting the closure of recalcitrant chronic ulcers. Healiva02, an allogeneic cell therapy targets venous leg ulcers. We are further developing 2 in-house products, the world`s first-in class spray based debrider and an autologous blood component patch.

Cooperation possibilities

Out-licensing, Business Development, Distribution.

Open to partner/ collaborate with hospitals, medical practitioners, insurance providers and patients associations.

Some insights
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland

You may also be interested in